Table 7.
Other modified carvedilol derivatives as SOICR inhibitors
| entry | compound | structure | IC50 (μM) ± SEM | repeats (n) | no. of cells |
|---|---|---|---|---|---|
| 1 | 81 |
|
>1000 | 3 | 193 |
| 2 | 82 |
|
>1000 | 3 | 234 |
| 3 | 83 |
|
5.76 ± 1.3 | 4 | 299 |
| 4 | 84 |
|
15.8 ± 5.0 | 3 | 171 |
| 5 | 85 |
|
19.7 ± 9.0 | 3 | 188 |
| 6 | 86 |
|
8.61 ± 0.47 | 3 | 218 |
| 7 | 87 |
|
>1000 | 3 | 153 |
| 8 | 88 |
|
>1000 | 3 | 191 |
| 9 | 89 |
|
34.9 ± 3.7 | 3 | 148 |
| 10 | 90 |
|
62.7 ± 15 | 4 | 201 |
| 11 | 91 |
|
19.8 ± 1.7 | 3 | 187 |
| 12 | 92 |
|
94.5 ± 60 | 3 | 216 |
| 13 | 93 |
|
3.55 ± 0.30 | 3 | 158 |
| 14 | 94 |
|
3.63 ± 0.18 | 3 | 127 |